Skip to Main Content

The (POGO) Blog

June 1, 2017

By Scott H. Amey, J.D.

White House Releases Ethics Waivers After Battle with OGE



White House Ethics Waiver The White House reversed its decision to fight the Office of Government Ethics over the release of government ethics records the day after POGO requested that it should proactively release copies of ethics waivers on public websites.

Continue Reading White House Releases Ethics Waivers After Battle with OGE

Topics: Government Accountability

May 17, 2017

By Danielle Brian

In Push for FBI Director James Comey's Trump Memos, Congress Must Protect Whistleblowers



Whistleblower whistle News reports that FBI Director James Comey documented President Trump's attempt to improperly influence FBI investigations raise serious concerns about the President and the rule of law.

Continue Reading In Push for FBI Director James Comey's Trump Memos, Congress Must Protect Whistleblowers

Topics: Government Accountability, Whistleblower Protections

April 6, 2017

By Nick Schwellenbach

Advisors to the President Should Be Subject to Ethics Laws



Stephen Feinberg In a letter to White House Counsel, POGO urged the White House to make Stephen Feinberg and Carl Icahn subject to federal ethics laws given their vast conflicts of interest.

Continue Reading Advisors to the President Should Be Subject to Ethics Laws

Topics: Government Accountability

March 13, 2017

By Nick Schwellenbach

Trump’s Trademarks Pose Ethics Challenge for the Executive Branch



Trump President Trump has trademark litigation before an executive branch panel—these judges ultimately work for Trump. Can they neutrally preside over a case involving him?

Continue Reading Trump’s Trademarks Pose Ethics Challenge for the Executive Branch

Topics: Government Accountability

February 22, 2017

By Ned Feder, M.D.

Let There Be Light: The FDA's Surprising New Policy



FDA Shrouded in Darkness - the Food and Drug Administration building and sign The Food and Drug Administration has a brand-new policy bringing greater transparency regarding the agency's advisory committee members. The increased transparency will help address concerns over these members' conflicts of interest and the advice they giv

Continue Reading Let There Be Light: The FDA's Surprising New Policy

Topics: Government Accountability, Open Government, Public Health and Science

Items 6 - 10 of 29  Previous123456Next

Browse POGOBlog by Topic

POGO on Facebook